News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hospira, Inc. (HSP)'s Lidocaine Injection Recalled In 28 States


12/27/2013 7:03:08 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Hospira Inc. has initiated a voluntary nationwide recall to the user level for one lot of Lidocaine HCl Injection because of a reddish orange particulate on the inner surface and floating in the solution. The recalled lot is Lidocaine HCl, USP, 2%, 5 mL single-dose vial (NDC 0409-2066-05), Lot 32-135-DD, expiration date Aug. 1, 2015. Lidocaine is packaged 10 units per carton/180 units per case in single dose glass fliptop vials.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES